(Q41767448)

9 October 2017

Immunochemotherapy against colon cancer by gene transfer of interleukin-12 in combination with oxaliplatin (English)

1 reference

9 October 2017

1 reference

Ruben Hernandez-Alcoceba

series ordinal

1

1 reference

PMC publication ID

3376956

9 October 2017

Pedro Berraondo

series ordinal

2

1 reference

9 October 2017

1 January 2012

1 reference

9 October 2017

1 reference

9 October 2017

1

1 reference

9 October 2017

1

1 reference

9 October 2017

97-99

1 reference

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

9 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Immunogenic death of colon cancer cells treated with oxaliplatin

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Myeloid-derived suppressor cells as regulators of the immune system

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Interleukin-12: biological properties and clinical application

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

Interleukin-12 inhibits liver-specific drug-inducible systems in vivo

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376956

18 August 2018

Identifiers

DOI

10.4161/ONCI.1.1.17930

1 reference

9 October 2017

1 reference

PMC publication ID

3376956

9 October 2017

PubMed publication ID

22720223

1 reference

PMC publication ID

3376956